Altshuler Shaham LTD Regenxbio Inc. Transaction History

Altshuler Shaham LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 13, 2020	SELL	$27.75 - $43.44 $196,248 - $307,207	-7,072 Closed	0 $0
Q1 2020 May 12, 2020	SELL	$21.5 - $54.2 $55,663 - $140,323	-2,589 Reduced 26.8%	7,072 $229,000
Q3 2019 Nov 12, 2019	BUY	$31.84 - $50.88 $6,654 - $10,633	209 Added 2.21%	9,661 $332,000
Q2 2019 Aug 06, 2019	BUY	$42.0 - $59.29 $37,296 - $52,649	888 Added 10.37%	9,452 $486,000
Q4 2018 Feb 11, 2019	SELL	$39.11 - $75.15 $243,459 - $467,808	-6,225 Reduced 42.09%	8,564 $359,000
Q2 2018 Aug 13, 2018	SELL	$27.2 - $74.35 $217,600 - $594,800	-8,000 Reduced 35.1%	14,789 $1.06 Million
Q1 2018 May 15, 2018	SELL	$24.05 - $37.5 $9,884 - $15,412	-411 Reduced 1.77%	22,789 $680,000
Q4 2017 May 14, 2018	BUY	$26.0 - $34.6 $603,200 - $802,720	23,200	23,200 $771,000

196

43M

104K

478K

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $329M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.